Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at Very High Cardiovascular Risk in the United Kingdom: Results from a General Practice Population Study

The United Kingdom ◽

Practice Population ◽

Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany

Atherosclerosis ◽

10.1016/j.atherosclerosis.2017.11.020 ◽

2018 ◽

Vol 268 ◽

pp. 99-107 ◽

Cited By ~ 25

Author(s):

Winfried März ◽

Franz-Werner Dippel ◽

Karlheinz Theobald ◽

Katherine Gorcyca ◽

Şerban R. Iorga ◽

...

Keyword(s):

Cardiovascular Risk ◽

Goal Attainment ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Real World Evidence ◽

Cholesterol Goal ◽

CONSISTENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL LOWERING EFFICACY OF ALIROCUMAB IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH LOW-DENSITY LIPOPROTEIN CHOLESTEROL >100/70 MG/DL AT BASELINE

10.1016/s0735-1097(17)35101-x ◽

2017 ◽

Vol 69 (11) ◽

pp. 1712

Author(s):

Jennifer Robinson ◽

Francois Schiele ◽

Ulrich Laufs ◽

Maddalena Lettino ◽

Velichka Valcheva ◽

...

Keyword(s):

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Lowering ◽

Risk Patients ◽

Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk

Patient Preference and Adherence ◽

10.2147/ppa.s182765 ◽

2018 ◽

Vol Volume 13 ◽

pp. 9-19 ◽

Cited By ~ 6

Author(s):

Julius Katzmann ◽

Felix Mahfoud ◽

Michael Böhm ◽

Martin Schulz ◽

Ulrich Laufs

Keyword(s):

Blood Pressure ◽

Cardiovascular Risk ◽

Medication Adherence ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

High Cardiovascular Risk

Switching From Atorvastatin to Simvastatin in Patients at High Cardiovascular Risk: Effects on Low-Density Lipoprotein Cholesterol

American Journal of Therapeutics ◽

10.1097/mjt.0b013e3181b442b9 ◽

2010 ◽

Vol 17 (2) ◽

pp. 167-175 ◽

Cited By ~ 20

Author(s):

Herbert D Aronow ◽

Gregory Hess ◽

Jerrold Hill ◽

Andreas Kuznik ◽

Larry Z Liu

Keyword(s):

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Risk Effects

GETTING TO AN IMPROVED UNDERSTANDING OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND DYSLIPIDEMIA MANAGEMENT (GOULD): A REGISTRY OF HIGH CARDIOVASCULAR RISK PATIENTS IN THE UNITED STATES

10.1016/s0735-1097(18)32308-8 ◽

2018 ◽

Vol 71 (11) ◽

pp. A1767

Author(s):

Christopher P. Cannon ◽

James de Lemos ◽

Robert Rosenson ◽

Christie Ballantyne ◽

Brian Boatman ◽

...

Keyword(s):

United States ◽

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

The United States ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Risk Patients

The Association of Small Dense Low-Density Lipoprotein Cholesterol and Coronary Heart Disease in Subjects at High Cardiovascular Risk

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.55350 ◽

2021 ◽

Vol 28 (1) ◽

pp. 79-89 ◽

Cited By ~ 1

Author(s):

Mayu Higashioka ◽

Satoko Sakata ◽

Takanori Honda ◽

Jun Hata ◽

Mao Shibata ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

High Cardiovascular Risk

LONG-TERM RENAL FUNCTION WORSENS IN HIGH CARDIOVASCULAR RISK PATIENTS WITH HIGH TRIGLYCERIDES AND WELL-CONTROLLED LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN A REAL-WORLD ANALYSIS

10.1016/s0735-1097(18)31986-7 ◽

2018 ◽

Vol 71 (11) ◽

pp. A1445 ◽

Cited By ~ 1

Author(s):

Peter Toth ◽

Craig Granowitz ◽

Michael Hull ◽

Djibril Liassou ◽

Amy Anderson ◽

...

Keyword(s):

Renal Function ◽

Cardiovascular Risk ◽

Real World ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Risk Patients

Distance To Targets Of Low-Density Lipoprotein Cholesterol And Eligibility For Treatment With Pcsk9 Inhibitors In Patients At High Cardiovascular Risk

Atherosclerosis ◽

10.1016/j.atherosclerosis.2019.06.561 ◽

2019 ◽

Vol 287 ◽

pp. e185-e186

Author(s):

F. Barkas ◽

M. Elisaf ◽

T. Dimitriou ◽

G. Liamis ◽

E. Rizos ◽

...

Keyword(s):

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Pcsk9 Inhibitors

Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan

Atherosclerosis ◽

10.1016/j.atherosclerosis.2016.07.001 ◽

2016 ◽

Vol 251 ◽

pp. 248-254 ◽

Cited By ~ 39

Author(s):

Tamio Teramoto ◽

Kiyoko Uno ◽

Izuru Miyoshi ◽

Irfan Khan ◽

Katherine Gorcyca ◽

...

Keyword(s):

Cardiovascular Risk ◽

Real World ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Prescription Patterns ◽

Cholesterol Levels ◽

Risk Patients

LOWER ON-TREATMENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL IS ASSOCIATED WITH LOWER CARDIOVASCULAR RISK IN VERY HIGH RISK PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: ANALYSES FROM THE ODYSSEY TRIALS

10.1016/s0735-1097(17)33444-7 ◽

2017 ◽

Vol 69 (11) ◽

pp. 55 ◽

Cited By ~ 1

Author(s):

Kausik Kumar Ray ◽

Antonio Vallejo-Vaz ◽

Henry Ginsberg ◽

Michael Davidson ◽

Robert H. Eckel ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cardiovascular Risk ◽

High Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Atherosclerotic Cardiovascular Disease ◽

Low Density ◽

Risk Patients ◽